Our Team

UVM CORA is led by University of Vermont faculty who have over three decades of engagement in innovative research and clinical efforts to develop novel treatments for opioid use disorder (OUD). Our work began with the seminal studies demonstrating buprenorphine treatment efficacy, which contributed to its FDA approval. Our center’s team of clinicians, faculty, and staff have extensive backgrounds and expertise in public health, research, and treatment of substance use disorders (SUDs).